Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-START: Low Dose Steroid for ARDS After Thoracic Surgery
NCT00290602Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Feb 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in acute respiratory distress syndrome (ARDS), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Feb 2004; status: completed.
02
Drugs
methylprednisolone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00290602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290602.